NASDAQ:KERN Akerna (KERN) Stock Forecast, Price & News $0.71 0.00 (0.00%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$0.70▼$0.7450-Day Range$0.69▼$0.8552-Week Range$0.66▼$8.80Volume29,580 shsAverage Volume365,632 shsMarket Capitalization$4.07 millionP/E RatioN/ADividend YieldN/APrice Target$1.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Akerna MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside41.6% Upside$1.00 Price TargetShort InterestHealthy1.48% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.95Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.92 out of 5 stars 3.0 Analyst's Opinion Consensus RatingAkerna has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.00, Akerna has a forecasted upside of 41.6% from its current price of $0.71.Amount of Analyst CoverageAkerna has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.48% of the float of Akerna has been sold short.Short Interest Ratio / Days to CoverAkerna has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Akerna has recently decreased by 9.83%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAkerna does not currently pay a dividend.Dividend GrowthAkerna does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KERN. Previous Next 3.3 News and Social Media Coverage News SentimentAkerna has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Akerna this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Akerna to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Akerna insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.15% of the stock of Akerna is held by insiders. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Akerna is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Akerna is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Akerna (NASDAQ:KERN) StockAkerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. Further, it provides cannabis cultivation management and compliance software; and cannabis tracking technology that offers seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.Read More Receive KERN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akerna and its competitors with MarketBeat's FREE daily newsletter. Email Address KERN Stock News HeadlinesJune 7, 2023 | americanbankingnews.comAkerna Corp. (NASDAQ:KERN) Forecasted to Post Q2 2023 Earnings of ($0.32) Per ShareJune 6, 2023 | finance.yahoo.comAll You Need to Know About Akerna Corp. (KERN) Rating Upgrade to BuyJune 9, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!June 3, 2023 | msn.comHC Wainwright & Co. Reiterates Akerna (KERN) Neutral RecommendationMay 17, 2023 | finance.yahoo.comAkerna First Quarter 2023 Earnings: US$0.48 loss per share (vs US$13.89 loss in 1Q 2022)May 1, 2023 | finanznachrichten.deAkerna Corp.: Akerna Announces Sale of Software Business to MJ Freeway Acquisition Co, Coinciding with Merger with Gryphon Digital MiningApril 29, 2023 | marketwatch.comAkerna to Sell its Cannabis Software BusinessApril 29, 2023 | msn.comAkerna divests its cannabis software business to SPAC MJ FreewayJune 9, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...April 28, 2023 | finance.yahoo.comAkerna Announces Sale of Software Business to MJ Freeway Acquisition Co, Coinciding with Merger with Gryphon Digital MiningApril 26, 2023 | finance.yahoo.comGryphon Digital Mining to Present at the Ladenburg Thalmann Tech Expo 2023April 7, 2023 | finance.yahoo.comAkerna Receives Superior Acquisition Proposal, Terminates Agreement with POSaBITMarch 24, 2023 | americanbankingnews.comAkerna (NASDAQ:KERN) PT Lowered to $1.00 at HC WainwrightMarch 21, 2023 | finance.yahoo.comAkerna Announces Financial Results for Fourth Quarter and Full Year 2022February 15, 2023 | finance.yahoo.comAkerna Provides Update on Recently Announced TransactionsFebruary 1, 2023 | finance.yahoo.comAkerna Regains Compliance with NASDAQ Continued Listing RequirementsJanuary 12, 2023 | benzinga.comWhy Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving PremarketNovember 29, 2022 | finance.yahoo.comPass the Pre-Rolls, Please: Thanksgiving Holiday Cannabis Sales See Double-Digit Year-Over-Year GrowthNovember 14, 2022 | finance.yahoo.comAkerna Corp. (KERN) Reports Q3 Loss, Misses Revenue EstimatesNovember 14, 2022 | finance.yahoo.comAkerna Announces Financial Results for Third Quarter 2022November 8, 2022 | finance.yahoo.comAkerna Corp. Announces Intent to Effect Reverse Stock SplitNovember 7, 2022 | finance.yahoo.comAkerna to Announce Financial Results for the Third Quarter of 2022 on November 14, 2022November 6, 2022 | benzinga.comAkerna Report: Haloween Cannabis Sales Grew 6%YoY, Reaching Almost $250MNovember 6, 2022 | benzinga.comAkerna Report: Halloween Cannabis Sales Grew 6%YoY, Reaching Almost $250MNovember 4, 2022 | finance.yahoo.comAkerna Flash Report: Halloween Weekend Cannabis Sales Total $249.6 MillionOctober 19, 2022 | streetinsider.comForm DEF 14A Akerna Corp. For: Nov 07 - StreetInsider.comOctober 13, 2022 | marketscreener.comAkerna To Participate In LD Micro Main Event XV - Marketscreener.comSee More Headlines KERN Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KERN Company Calendar Last Earnings3/21/2023Today6/09/2023Next Earnings (Estimated)8/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Data processing & preparation Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:KERN CUSIPN/A CIK1755953 Webwww.akerna.com Phone888-932-6537FaxN/AEmployees204Year FoundedN/APrice Target and Rating Average Stock Price Forecast$1.00 High Stock Price Forecast$1.00 Low Stock Price Forecast$1.00 Forecasted Upside/Downside+40.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($23.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-79,060,000.00 Net Margins-351.55% Pretax Margin-239.57% Return on Equity-475.50% Return on Assets-56.15% Debt Debt-to-Equity Ratio0.26 Current Ratio0.24 Quick Ratio0.24 Sales & Book Value Annual Sales$13.65 million Price / Sales0.30 Cash FlowN/A Price / Cash FlowN/A Book Value($1.52) per share Price / Book-0.47Miscellaneous Outstanding Shares5,770,000Free Float5,585,000Market Cap$4.10 million OptionableNot Optionable Beta2.74 Key ExecutivesMs. Jessica Billingsley (Age 45)Founder, CEO & Chairman Comp: $476.14kMr. David R. McCullough (Age 46)Chief Technology Officer Comp: $260.07kMr. Larry Dean Ditto Jr. (Age 55)Chief Financial Officer Georgia JablonCommunications Mang.Key CompetitorsNantHealthNASDAQ:NHIQNantHealthNASDAQ:NHIMACNASDAQ:BACKHistogenNASDAQ:HSTOInVivo TherapeuticsNASDAQ:NVIVView All CompetitorsInstitutional OwnershipK2 Principal Fund L.P.Bought 48,877 shares on 5/11/2023Ownership: 1.215%View All Institutional Transactions KERN Stock - Frequently Asked Questions Should I buy or sell Akerna stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akerna in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KERN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KERN, but not buy additional shares or sell existing shares. View KERN analyst ratings or view top-rated stocks. What is Akerna's stock price forecast for 2023? 1 equities research analysts have issued 1 year price objectives for Akerna's shares. Their KERN share price forecasts range from $1.00 to $1.00. On average, they anticipate the company's stock price to reach $1.00 in the next twelve months. This suggests a possible upside of 40.8% from the stock's current price. View analysts price targets for KERN or view top-rated stocks among Wall Street analysts. How have KERN shares performed in 2023? Akerna's stock was trading at $0.6902 on January 1st, 2023. Since then, KERN shares have increased by 2.9% and is now trading at $0.71. View the best growth stocks for 2023 here. When is Akerna's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our KERN earnings forecast. How were Akerna's earnings last quarter? Akerna Corp. (NASDAQ:KERN) issued its earnings results on Tuesday, March, 21st. The company reported ($0.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.71) by $0.19. The firm earned $2.85 million during the quarter, compared to analysts' expectations of $6.44 million. Akerna had a negative net margin of 351.55% and a negative trailing twelve-month return on equity of 475.50%. What ETF holds Akerna's stock ? Amplify Seymour Cannabis ETF holds 13,217 shares of KERN stock, representing 0.04% of its portfolio. What other stocks do shareholders of Akerna own? Based on aggregate information from My MarketBeat watchlists, some companies that other Akerna investors own include KushCo (KSHB), Organigram (OGI), Supreme Cannabis (SPRWF), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Medical Marijuana (MJNA), MariMed (MRMD), Matinas BioPharma (MTNB), CNBX Pharmaceuticals (CNBX) and DHT (DHT). What is Akerna's stock symbol? Akerna trades on the NASDAQ under the ticker symbol "KERN." Who are Akerna's major shareholders? Akerna's stock is owned by many different retail and institutional investors. Top institutional investors include K2 Principal Fund L.P. (1.22%). Insiders that own company stock include Jessica Billingsley and Matthew Ryan Kane. View institutional ownership trends. How do I buy shares of Akerna? Shares of KERN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Akerna's stock price today? One share of KERN stock can currently be purchased for approximately $0.71. How much money does Akerna make? Akerna (NASDAQ:KERN) has a market capitalization of $4.10 million and generates $13.65 million in revenue each year. The company earns $-79,060,000.00 in net income (profit) each year or ($23.45) on an earnings per share basis. How many employees does Akerna have? The company employs 204 workers across the globe. How can I contact Akerna? Akerna's mailing address is 1601 ARAPAHOE STREET, DENVER CO, 80202. The official website for the company is www.akerna.com. The company can be reached via phone at 888-932-6537 or via email at ir@akerna.com. This page (NASDAQ:KERN) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akerna Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.